logo
Biden's former doctor refuses to answer questions in House Republican probe

Biden's former doctor refuses to answer questions in House Republican probe

Yahoo09-07-2025
WASHINGTON (AP) — President Joe Biden's former White House physician is refusing to answer questions as part of the House Republican investigation into Biden's health in office.
Dr. Kevin O'Connor invoked doctor-client privilege and his rights under the Fifth Amendment during an appearance Wednesday before the House Oversight Committee, his attorneys said.
Republicans are conducting a sweeping investigation into Biden's actions in office and questioning whether the Democrat's use of an autopen in office may have been invalid. They have also claimed that some policies carried out by the White House autopen may be invalid if it is proven that Biden was mentally incapacitated for some part of his term.
Biden has strongly denied that he was not in a right state of mind at any point while in office, calling the claims 'ridiculous and false.'
David Schertler, one of O'Connor's lawyers, said in a written statement he prepared for the committee that the doctor would not violate his oath of confidentiality with his patients. He also said the House Oversight committee should hold off on its investigation until Attorney General Pam Bondi concludes an investigation that the Oversight Committee's chair, Rep. James Comer of Kentucky, said she has launched into the use of the autopen.
'The pending Department of Justice criminal investigation leaves Dr. O'Connor no choice but to invoke his constitutional rights under the Fifth Amendment of the Constitution to any questions posed by the Committee,' Schertler said in the statement.
Comer, in a statement, said O'Connor's decision not to testify made it 'clear there was a conspiracy."
'The American people demand transparency, but Dr. O'Connor would rather conceal the truth,' Comer said.
In a June subpoena of O'Connor, Comer said that claims of physician-patient privilege under the American Medical Association's code of ethics 'lack merit' because that code is not part of federal law. He said the committee's subpoena meets the AMA's own requirement that physicians must share a patient's medical information if 'legally compelled to disclose the information' or 'ordered to do so by legally constituted authority.'
Comer has said his committee will release a report of all its findings after the probe is complete. He has issued subpoenas for O'Connor and Anthony Bernal, former chief of staff to former first lady Jill Biden. Last month, Neera Tanden, former director of Biden's domestic policy counsel, gave voluntary testimony.
Comer has requested testimony from nearly a dozen former senior Biden aides, including former White House chiefs of staff Ron Klain and Jeff Zients; former senior advisers Mike Donilon and Anita Dunn; former deputy chief of staff Bruce Reed, former counselor to the president Steve Ricchetti, former deputy chief of staff Annie Tomasini and a former assistant to the president, Ashley Williams.
President Donald Trump's White House has waived executive privilege, a right that protects many communications between the president and staff from Congress and the courts, for almost all of those senior staffers. That clears the way for those staffers to discuss their conversations with Biden while he was president.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

Yahoo

time11 minutes ago

  • Yahoo

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

WASHINGTON (AP) — U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk. The agency said the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA. Defibrillators are surgically placed in the upper chest, where they monitor irregular heartbeats and use electrical shocks to jolt the heart back to normal. As of July 24, Boston Scientific has reported 386 serious injuries and 16 deaths associated with this issue, the agency said. Ten of the deaths were judged to be due to the device failing to function properly, the company said in an email. Four were linked to attempts to surgically remove the devices from patients and two others were deemed unrelated to the implants. Boston Scientific's wires were distributed between 2002 and 2021 and are no longer available, the company noted in its letter to doctors. Some patients will need to have the devices replaced, though physicians should weigh the risks of the removal procedure. In a separate notice, the FDA said Boston Scientific recently updated instructions for implanting its Watchman device, which closes a portion of the heart's left atrium to reduce the risk of stroke. In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the level of anesthesia for patients undergoing the initial implantation procedure. Watchman is an alternative to long-term treatment with blood thinners for patients at increased risk of stroke. As of July 30, the company has reported 120 serious injuries and 17 deaths related to the issue, the FDA said. A company investigation concluded that the safety issue 'is not associated with the design or manufacture of any component of the Watchman system. Heart devices, including defibrillators and other implants, are Boston Scientific's largest business, making up two-thirds of its $5 billion in revenue for the most recent quarter. Shares of Boston Scientific Corp. fell nearly 1.8 percent Wednesday to close at $102.95 in trading. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

Rancho Palos Verdes to ban new construction in landslide zone
Rancho Palos Verdes to ban new construction in landslide zone

Yahoo

time11 minutes ago

  • Yahoo

Rancho Palos Verdes to ban new construction in landslide zone

Rancho Palos Verdes has moved forward with plans to permanently ban new construction across 715 acres of land that has been plagued by dramatic and destructive landslide movement over the last two years. City councilmembers on Tuesday night voted unanimously to prohibit almost all new development, including home additions, throughout the landslide zone, which encompasses approximately 400 homes and 130 vacant, privately owned lots across three neighborhoods. The change to the city's building code would, however, permit repairs, restoration efforts and even the replacement of existing homes, so long as the updates don't exceed the original, damaged home's square footage. It also provides for a way for land owners to apply for an exception. Tuesday's vote is the first step to make permanent a moratorium that had been in place since land movement dramatically accelerated almost two years ago. The change will only take place after a final approval later this month. But with overwhelming support from city leaders, it appears likely to go into effect by the end of September. Read more: Is it finally time to ban new homes in the Rancho Palos Verdes' landslide zone? Despite well-documented issues from the landslide since October 2023, the move faces opposition, especially from homeowners who live in areas that have recently stabilized. Criticism and concern have also come from landowners sitting on undeveloped lots, or from homeowners who were recently included in the designated landslide zone. That designation came after geologists confirmed that the recent movement had expanded past historic boundaries. Many other homeowners, however, said they were in support of the ban. City officials said the changes were about safety, and pointed to the last two years of unprecedented landslide movement. The movement has fractured homes, warped several roads and severed shut off electricity and gas service for hundreds. Though the area has long been known for recurring issues from a complex of ancient landslides that reemerged in the 1950s, the rate and scale of the movement since October 2023 has never before been recorded. 'We're very sensitive about the land and the folks that are now included in this [prohibition] zone," Mayor Pro Tem Paul Seo said at Tuesday's city council meeting. "... But what it comes down to is public safety and well-being for the people on that land.' The city had enacted a similar ban on development in the landslide zone decades ago, but it was repeatedly weakened by lawsuits and exceptions. City leaders on Tuesday said that some of the homes damaged in the recent movement were among a group that fought the initial construction ban, and won approval to build in the landslide zone through a lawsuit in the early 2000s. At least five recently applied for federal buyouts, city officials said. Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week. This story originally appeared in Los Angeles Times.

Trump met Citigroup, BofA CEOs to discuss Fannie and Freddie, sources say
Trump met Citigroup, BofA CEOs to discuss Fannie and Freddie, sources say

Yahoo

time11 minutes ago

  • Yahoo

Trump met Citigroup, BofA CEOs to discuss Fannie and Freddie, sources say

NEW YORK (Reuters) -U.S. President Donald Trump met Citigroup CEO Jane Fraser at the White House on Wednesday to discuss the administration's plans for Fannie Mae and Freddie Mac, according to a source familiar with the situation. Trump also met with Bank of America CEO Brian Moynihan and his team to discuss Fannie and Freddie, a separate source said. The administration had previously said it plans to take the firms public, but will keep oversight and guarantees in the mortgage market. The White House declined to comment on private meetings.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store